• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

MEI Pharma Inc

+ Add to Watchlist

MEIP:US

8.4800 USD 0.1700 1.97%

As of 20:10:00 ET on 04/17/2014.

Snapshot for MEI Pharma Inc (MEIP)

Open: 8.6200 Day's Range: 8.2800 - 8.7400 Volume: 65,576
Previous Close: 8.6500 52wk Range: 6.5200 - 13.9800 1-Yr Rtn: -4.50%

Stock Chart for MEIP

No chart data available.
  • MEIP:US 8.4800
  • 1D
  • 1M
  • 1Y
8.6500
Interactive MEIP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MEIP

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9828
Est. EPS (USD) (06/2014) -1.2750
Est. PEG Ratio -
Market Cap (M USD) 182.28
Shares Outstanding (M) 21.50
30 Day Average Volume 302,635
Price/Book (mrq) 3.1038
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MEIP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MEIP

MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company's lead drug candidates have been shown in laboratory studies to interact with specific enzyme targets resulting in inhibition of tumor cell metabolism, a function critical for cancer cell survival.

Daniel P GoldPresident/CEOThomas M ZechCFO/Secretary
Robert D MassChief Medical OfficerDavid M UrsoSenior VP:Corporate Dev
More Company Profile & Key Executives for MEIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil